Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications

Filomena Freitas; Christophe Roca; Maria A.M. Reis

doi:10.1002/9781119041450.ch3

Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications

Filomena Freitas, Christophe Roca, Maria A.M. Reis

Research output: Chapter in Book/Report/Conference proceeding › Chapter › peer-review

13 Citations (Scopus)

Abstract

Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.

Original language	English
Title of host publication	Handbook of Polymers for Pharmaceutical Technologies
Subtitle of host publication	Biodegradable Polymers
Publisher	Wiley
Pages	61-103
Number of pages	43
Volume	3
ISBN (Electronic)	978-111904145-0
ISBN (Print)	978-111904142-9
DOIs	https://doi.org/10.1002/9781119041450.ch3
Publication status	Published - 19 Sept 2015

Keywords

Chitin
Chitosan
Fungi
Glucans
Mannans
Polysaccharides
Yeast

Access to Document

10.1002/9781119041450.ch3

Cite this

@inbook{029a04d11b3841048c746ccf189d3778,

title = "Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications",

abstract = "Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.",

keywords = "Chitin, Chitosan, Fungi, Glucans, Mannans, Polysaccharides, Yeast",

author = "Filomena Freitas and Christophe Roca and Reis, {Maria A.M.}",

year = "2015",

month = sep,

day = "19",

doi = "10.1002/9781119041450.ch3",

language = "English",

isbn = "978-111904142-9",

volume = "3",

pages = "61--103",

booktitle = "Handbook of Polymers for Pharmaceutical Technologies",

publisher = "Wiley",

address = "Germany",

}

TY - CHAP

T1 - Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications

AU - Freitas, Filomena

AU - Roca, Christophe

AU - Reis, Maria A.M.

PY - 2015/9/19

Y1 - 2015/9/19

N2 - Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.

AB - Biodegradable and biocompatible polysaccharides of fungal origin, such as cell wall polysaccharides (e.g., chitin, chitosan, glucans, mannans) and extracellular polysaccharides (EPS) (e.g., pullulan, scleroglucan), have been widely studied and proposed for a wide range of applications. Due to their properties, such polysaccharides have attracted increasing interest for pharmaceutical and biomedical applications, including in immunology and drug delivery systems. Many polysaccharides of fungal origin are currently being investigated for such uses in in-vitro and in-vivo clinical trials. Moreover, there are already several commercial fungal polysaccharides available, although most of them are marketed as natural products and their clinical use is still not widespread.

KW - Chitin

KW - Chitosan

KW - Fungi

KW - Glucans

KW - Mannans

KW - Polysaccharides

KW - Yeast

UR - http://www.scopus.com/inward/record.url?scp=85019498847&partnerID=8YFLogxK

U2 - 10.1002/9781119041450.ch3

DO - 10.1002/9781119041450.ch3

M3 - Chapter

AN - SCOPUS:85019498847

SN - 978-111904142-9

VL - 3

SP - 61

EP - 103

BT - Handbook of Polymers for Pharmaceutical Technologies

PB - Wiley

ER -

Fungi as Sources of Polysaccharides for Pharmaceutical and Biomedical Applications

Abstract

Keywords

Access to Document

Other files and links

Fingerprint

Cite this